NASDAQ:ARQT

Arcutis Biotherapeutics Stock Insider Trading

etoro logo Buy ARQT
*Your capital is at risk
$21.35
+0.560 (+2.69%)
At Close: Jun 03, 2026

Arcutis Biotherapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -66.86. In total, the insiders bought 1.14M and sold 561.57K ARQT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-66.86
Buy 1.14M shares
Sell 561.57K shares
33% Buy Activity
Weak Negative Correlation
Buy Signal Low Confidence
Feb 27, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -66.86.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Nov 13, 2025
Sell
Common Stock
S-Sale
Krishnamohan Neha
Director
Director 1 232
Value: $28.8K
Nov 13, 2025
Sell
Common Stock
S-Sale
Krishnamohan Neha
Director
Director 39 272
Value: $910.7K
Nov 13, 2025
Buy
Common Stock
M-Exempt
Krishnamohan Neha
Director
Director 27 052
Value: $233.5K
Nov 13, 2025
Buy
Common Stock
M-Exempt
Krishnamohan Neha
Director
Director 12 220
Value: $91.8K
Nov 06, 2025
Sell
Common Stock
S-Sale
Burnett Patrick
See Remarks
Officer 17 250
Value: $417.1K
Nov 06, 2025
Buy
Common Stock
M-Exempt
Burnett Patrick
See Remarks
Officer 17 250
Value: $62.8K
Nov 06, 2025
Buy
Stock Option (right to buy)
M-Exempt
Burnett Patrick
See Remarks
Officer 17 250
Value: $62.8K
Nov 06, 2025
Sell
Common Stock
S-Sale
Edwards Larry Todd
See Remarks
Officer 29 131
Value: $732.9K
Nov 05, 2025
Sell
Common Stock
S-Sale
Burnett Patrick
See Remarks
Officer 3 864
Value: $91.6K
Nov 03, 2025
Sell
Common Stock
S-Sale
Matsuda Masaru
See Remarks
Officer 43
Value: $1K
Nov 03, 2025
Sell
Common Stock
S-Sale
Matsuda Masaru
See Remarks
Officer 7 165
Value: $177.1K
Nov 03, 2025
Sell
Common Stock
S-Sale
Burnett Patrick
See Remarks
Officer 2 607
Value: $64.4K
Nov 03, 2025
Sell
Common Stock
S-Sale
Burnett Patrick
See Remarks
Officer 15
Value: $381
Nov 03, 2025
Sell
Common Stock
S-Sale
Welgus Howard G.
Director
Director 10 000
Value: $252.7K
Nov 03, 2025
Sell
Common Stock
S-Sale
Vairavan Latha
SVP Chief Financial Officer
C-Suite Officer 88
Value: $2K
Nov 03, 2025
Sell
Common Stock
S-Sale
Watanabe Todd
See Remarks
Officer 11 478
Value: $283.6K
Nov 03, 2025
Sell
Common Stock
S-Sale
Watanabe Todd
See Remarks
Officer 69
Value: $2K
Oct 28, 2025
Sell
Common Stock
S-Sale
Watanabe Todd
See Remarks
Officer 40 000
Value: $1.00M
Oct 02, 2025
Sell
Common Stock
S-Sale
Edwards Larry Todd
See Remarks
Officer 297
Value: $6K
Oct 02, 2025
Sell
Common Stock
S-Sale
Edwards Larry Todd
See Remarks
Officer 4 207
Value: $84.1K
Oct 02, 2025
Sell
Common Stock
S-Sale
Edwards Larry Todd
See Remarks
Officer 4 207
Value: $84.1K
Oct 02, 2025
Sell
Common Stock
S-Sale
Edwards Larry Todd
See Remarks
Officer 297
Value: $6K
Oct 01, 2025
Sell
Common Stock
S-Sale
Watanabe Todd
See Remarks
Officer 15 000
Value: $283.7K
Oct 01, 2025
Sell
Common Stock
S-Sale
Watanabe Todd
See Remarks
Officer 9 261
Value: $185.4K
Aug 18, 2022
Buy
Common Stock
A-Award
Burnett Patrick
See Remarks
Officer 16 750
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ARCUTIS BIOTHERAPEUTICS INC
Arcutis Biotherapeutics
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing ARQ-154, a topical foam formulation of roflumilast for the treatment of seborrheic dermatitis and scalp ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE